Sphingosine derivatives represented by general formula (I), or pharmaceutically acceptable salts thereof, wherein R<1> and R<2> are each hydrogen or the like; Z is NR<7> (wherein R<7> is hydrogen or the like); Y is oxygen or NR<8> (wherein R<8> is hydrogen or the like); W is oxygen or sulfur; and k is an integer of 1 to 20. The derivatives and the salts are useful as preventive or therapeutic drugs for cerebrovascular disorders such as cerebral hemorrhage and cerebral infarction; head injuries; senile dementia; degenerative diseases of cranial nerve such as Alzheimer disease and Parkinson disease; diabetes; obesity; arteriosclerosis; inflammatory diseases; immunologic diseases; cancers; kidney diseases; and heart diseases.
申请公布号
WO0138295(A1)
申请公布日期
2001.05.31
申请号
WO2000JP08229
申请日期
2000.11.22
申请人
TAISHO PHARMACEUTICAL CO.,LTD.;SAGAMI CHEMICAL RESEARCH CENTER;KOBORI, TAKEO;SUGIMOTO, KIKUO;GODA, KENICHI;TAGUCHI, MINORU